Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | Crystal Amber Fund Limited (Ordinary Share) | +62.84% |
NAV | Crystal Amber Fund Limited (Ordinary Share) | +53.00% |
Morningstar's Benchmark | Numis Smaller Companies TR GBP | +22.34% |
Announcements
- Monthly Net Asset Value
- Total Voting Rights
- Holding(s) in Company
- Transaction in Own Shares and Total Voting Rights
- Director/PDMR Shareholding
- Extension to Share Buyback Programme
- Investee company update: Morphic Medical Inc.
- Morphic Medical – FDA approval of study amendments
- Transaction in Own Shares
- Monthly Net Asset Value
More ▼
Key statistics
On Friday, Crystal Amber Fund Limited (CRS:LSE) closed at 108.00, -5.80% below its 52-week high of 114.65, set on Aug 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 71.55m |
---|---|
Market cap | 75.84m GBP |
Total assets | 121.90m GBP |
Total expense ratio | 1.53% |
High | 108.00 |
Low | 108.00 |
Previous close | 106.00 |
Average volume | 27.66k |
---|---|
YTD Change | +40.26% |
Beta | 1.4716 |
Diluted NAV (est) | 170.41 |
Diluted NAV (last pub) | 169.41 |
Premium/Discount | -36.11% |
Net Gearing | 0.00% |
Annual div (ADY) | -- |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Jun 15 2023 |
Div pay-date | Jul 07 2023 |
Data delayed at least 20 minutes, as of Oct 04 2024 15:49 BST.
More ▼